Development and Evaluation of Nasal Microsphere Formulations for Enhanced Nose-to-Brain Delivery of Lorazepam in Epilepsy
Abstract
This study developed and evaluated lorazepam-loaded nasal microspheres using carbopol 934 and chitosan polymers to enhance nose-to-brain drug delivery for epilepsy treatment. Microspheres were formulated via spray-drying with particle sizes ideal for nasal administration (5–50 µm) and characterized for particle size, yield, drug content, and release profiles. Analytical techniques, including IR spectroscopy, DSC, and FESEM, confirmed drug stability, polymer compatibility, and morphology. Drug release studies showed high release percentages (93.59% for LCH3 and 93.16% for LC3), with quasi-Fickian diffusion kinetics. In vivo studies in rats demonstrated significantly higher brain drug concentrations for the optimized formulations, LCH3 (143.07%) and LC3 (150.70%), compared to pure lorazepam. These findings highlight the potential of nasal microspheres as an effective and patient-friendly approach for rapid brain-targeted drug delivery in epilepsy management.
References
1. Potnis V V, Albhar KG, Nanaware PA, Pote VS. A review on epilepsy and its management. J Drug Deliv Ther. 2020;10(3):273–9.
2. Milligan TA. Epilepsy: a clinical overview. Am J Med. 2021;134(7):840–7.
3. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
4. Fisher RS, Ho J. Potential new methods for antiepileptic drug delivery. CNS Drugs. 2002;16:579–93.
5. Miyake MM, Bleier BS. The blood-brain barrier and nasal drug delivery to the central nervous system. Am J Rhinol Allergy. 2015;29(2):124–7.
6. Minn A, Leclerc S, Heydel JM, Minn AL, Denizot C, Cattarelli M, et al. Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier. J Drug Target. 2002;10(4):285–96.
7. Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003;255(1–2):13–32.
8. Jadhav S, Mishra S. The spray-dried mucoadhesive microparticles of rizatriptan with chitosan and carbopol in migraine. Egypt Pharm J. 2022;21(3):293–301.
9. Jadhav SM, Mishra SK. Spray Dried Mucoadhesive Microparticles of Donepezil with Chitosan and Carbopol in Alzheimer’s Disease. Int J Pharm Investig. 2022;12(2).
10. Desai PS, Pore YV. Physicochemical characterization of spray dried cefixime polymeric nanoparticles using factorial design approach. J Appl Pharm Sci. 2016;6(4):124–32.
11. Varela-Fernández R, Bendicho-Lavilla C, Martin-Pastor M, Vanrell RH, Lema-Gesto MI, González-Barcia M, et al. Design, optimization, and in vitro characterization of idebenone-loaded PLGA microspheres for LHON treatment. Int J Pharm. 2022;616:121504.
12. Shekunov BY, Chattopadhyay P, Tong HHY, Chow AHL. Particle size analysis in pharmaceutics: principles, methods and applications. Pharm Res. 2007;24:203–27.
13. Sipos P, Szabó A, Erős I, Szabó-Révész P. A DSC and Raman spectroscopic study of microspheres preparedwith polar cosolvents by different techniques. J Therm Anal Calorim. 2008;94(1):109–18.
14. Zhang L, Li Z, Lu T, He F, Ye J. Preparation and properties of porous calcium phosphate ceramic microspheres modified with magnesium phosphate surface coating for bone defect repair. Ceram Int. 2024;50(5):7514–27.
15. Bartos C, Szabó-Révész P, Horváth T, Varga P, Ambrus R. Comparison of modern in vitro permeability methods with the aim of investigation nasal dosage forms. Pharmaceutics. 2021;13(6):846.
16. Nair SC, Vinayan KP, Mangalathillam S. Nose to brain delivery of phenytoin sodium loaded nano lipid carriers: formulation, drug release, permeation and in vivo pharmacokinetic studies. Pharmaceutics. 2021;13(10):1640.
